Including R&D, Management , Marketing Center and Diagnostic production.
The mRNA vaccine production line is under construction.
The Capacity of Molecular Diagnostic Product and Immunological Diagnostic Product are 10,000 boxes respectively.

Established in 2014,Phase I and Phase II projects have been completed with an investment of 143 million RMB, Phase III project is under construction.
With the production pipelines :
•Foot-and-mouth disease of cell suspension culture inactivated vaccine production line
•Foot-and-mouth disease synthetic peptide vaccine production line
• Virus inactivated vaccine (including subunit vaccine) line on cell suspension culture production
•Inactivated veterinary vaccine production line
•Live veterinary vaccine production line